AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 194 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $132,000 | -6.4% | 14,000 | +20.8% | 0.01% | -14.3% |
| Q4 2019 | $141,000 | -2.1% | 11,590 | -7.3% | 0.01% | -12.5% |
| Q3 2019 | $144,000 | +23.1% | 12,500 | -0.8% | 0.01% | +33.3% |
| Q2 2019 | $117,000 | -29.9% | 12,600 | -3.1% | 0.01% | -25.0% |
| Q1 2019 | $167,000 | -15.2% | 13,000 | +0.3% | 0.01% | -27.3% |
| Q4 2018 | $197,000 | -35.2% | 12,956 | -14.8% | 0.01% | -15.4% |
| Q3 2018 | $304,000 | +1.3% | 15,200 | -1.3% | 0.01% | -7.1% |
| Q2 2018 | $300,000 | -1.3% | 15,400 | +2.0% | 0.01% | 0.0% |
| Q1 2018 | $304,000 | +51.2% | 15,100 | -0.7% | 0.01% | +55.6% |
| Q4 2017 | $201,000 | -23.9% | 15,200 | +6.3% | 0.01% | -25.0% |
| Q3 2017 | $264,000 | +0.4% | 14,300 | 0.0% | 0.01% | -7.7% |
| Q2 2017 | $263,000 | -16.8% | 14,300 | +2.1% | 0.01% | -18.8% |
| Q1 2017 | $316,000 | -34.2% | 14,000 | +1.4% | 0.02% | -36.0% |
| Q4 2016 | $480,000 | +29.7% | 13,800 | -8.6% | 0.02% | +31.6% |
| Q3 2016 | $370,000 | +1.1% | 15,100 | -1.3% | 0.02% | 0.0% |
| Q2 2016 | $366,000 | +1.7% | 15,300 | -0.6% | 0.02% | 0.0% |
| Q1 2016 | $360,000 | – | 15,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |